Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
Authors:
Open Access
- 1 May 2017
- journal article
- Vol. 18 (5) , 1225-1232
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- International validation of the Chinese University Prognostic Index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyChinese Journal of Cancer, 2014
- Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line ChemotherapyJNCI: Journal of the National Cancer Institute, 2013
- Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based ChemotherapyJNCI: Journal of the National Cancer Institute, 2013
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trialEuropean Journal of Cancer, 2012
- Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinionLiver International, 2010
- Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder CancerJournal of Clinical Oncology, 2006
- Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patientsLiver International, 2006
- Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy PathologyEuropean Urology, 2006
- Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomyCancer, 2005
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996